Pulmonary Nodules: Common Questions and Answers

Area of Science:

• Pulmonology
• Radiology
• Oncology

Background:

• Pulmonary nodules are frequently found incidentally or during lung cancer screening.
• Low-dose computed tomography (LDCT) screening in adults aged 50-80 with a significant smoking history reduces lung cancer mortality.
• Validated risk stratification models are crucial for assessing malignancy probability and guiding nodule management.

Purpose of the Study:

• To outline the current guidelines for managing pulmonary nodules detected via imaging.
• To emphasize the role of risk stratification in determining appropriate follow-up or intervention.
• To highlight strategies for improving adherence to established lung nodule management protocols.

Main Methods:

• Review of current clinical guidelines and risk stratification models for pulmonary nodules.
• Analysis of nodule characteristics (size, type - solid vs. subsolid) and patient risk factors.
• Discussion of imaging surveillance intervals and indications for advanced functional assessment or biopsy.

Main Results:

• Solid nodules <6 mm require surveillance in high-risk patients.
• Solid nodules 6-8 mm necessitate reassessment within 12 months, with flexible intervals based on risk and shared decision-making.
• Solid nodules ≥8 mm with high malignancy risk warrant positron emission tomography/computed tomography, biopsy, or resection.
• Subsolid nodules generally carry a higher cancer risk and require longer surveillance.

Conclusions:

• Effective management of pulmonary nodules relies on accurate risk assessment and adherence to size- and risk-based guidelines.
• Shared decision-making between physicians and patients is integral to nodule management.
• Implementation of clinical decision support tools and guideline integration in radiology reports can enhance guideline compliance.